NHeLP Condemns Mifepristone Ruling, Monitors Rapidly Shifting Legal Landscape
April 11, 2023
April 11, 2023
WASHINGTON, April 11 (TNSgov) -- The National Health Law Program issued the following news release:
The National Health Law Program is carefully monitoring the rapidly changing availability of mifepristone and the Food and Drug Administration's authority to regulate medication in light of two conflicting federal court rulings.
In the Texas case, Judge Matthew Kacsmaryk granted an injunction that may make mifepristone unavailable while a lawsuit challenging FDA approval . . .
The National Health Law Program is carefully monitoring the rapidly changing availability of mifepristone and the Food and Drug Administration's authority to regulate medication in light of two conflicting federal court rulings.
In the Texas case, Judge Matthew Kacsmaryk granted an injunction that may make mifepristone unavailable while a lawsuit challenging FDA approval . . .